Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2008-006238-87-GB
EUCTR2008-006238-87-GB
Active, not recruiting
Phase 1

Improving the safety and efficacy of anticoagulation therapy for thromboembolic disease through vitamin K - Improving stability of anticoagulation through vitamin K

ewcastle upon Tyne Hospitals NHS Foundation Trust0 sites180 target enrollmentOctober 14, 2009
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPatients will be recruited who are receiving long term warfarin therapy for the treatment or prevention of venous or arterial thrombosis or embolism

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Patients will be recruited who are receiving long term warfarin therapy for the treatment or prevention of venous or arterial thrombosis or embolism
Sponsor
ewcastle upon Tyne Hospitals NHS Foundation Trust
Enrollment
180
Status
Active, not recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 14, 2009
End Date
November 15, 2012
Last Updated
6 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
ewcastle upon Tyne Hospitals NHS Foundation Trust

Eligibility Criteria

Inclusion Criteria

  • •Adult patients with indications for at least 6 months anticoagulation therapy with warfarin with target INR 2\-3 attending the Newcastle upon Tyne Anticoagulant Monitoring Service.
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Abnormal biochemical tests of hepatic or renal function, cognitive impairment.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Improving the safety and efficacy of anticoagulation therapyTopic: BloodSubtopic: Blood (all Subtopics)Disease: Non-malignant haematologyHaematological DisordersAnticoagulation
ISRCTN64826232ewcastle upon Tyne Hospitals NHS Foundation Trust (UK)180
Not yet recruiting
Not Applicable
The efficacy and safety of anticoagulant therapy Arixtra Injection for the prevention of the vein thromboembolism in laparoscopic colorectal surgerycolorectal cancer
JPRN-UMIN000007005Osaka Medical College200
Completed
Not Applicable
Efficacy and safety of anticoagulant treatment using new alternative antithrombotic agents in acute cardioembolic stroke with nonvalvular atrial fibrillation.cerebral infarction
JPRN-UMIN000010477Department of Neurology, Kansai Medical University50
Recruiting
Not Applicable
Efficacy and safety of anticoagulant treatment using New oral anticoagulant (edoxaban) in atrial fibrillation after cardiac surgery.arterial fibrillation after cardiac surgery (nonvalvular disease)
JPRN-UMIN000021138ihon University school of medicine150
Completed
Not Applicable
A Study of Safety and efficacy of anticoagulant therapy in the treatment of Atrial Fibrillation in KANAGAWAAtrial fibrillation
JPRN-UMIN000011830ASSAF-K steering committee5,000